Back to guides

Mounjaro 10 mg: A Titration Milestone

Discreet next day delivery
100% UK-based pharmacy
Free advice and support
We're rated 4.7 out of 5
Mounjaro 10 mg once weekly is one of the three recommended maintenance doses, alongside 5 and 15 mg. It is reached by stepping up in 2.5 mg increments from 5 mg, through 7.5 mg. In the weight management trials, nausea at 10 mg was reported by around 29.0 percent of people, mostly mild to moderate. It is a prescription-only medicine assessed individually.
Reaching Mounjaro 10 mg feels like a milestone for a lot of people, because it is the first of the higher maintenance doses and often where the dose settles. It naturally raises questions about how the side effects compare, whether to go higher, and what 10 mg actually represents.

This guide covers the 10 mg dose specifically: where it sits, how you get there, the side effects reported at this strength, and how it compares to the other doses. It draws on the UK Summary of Product Characteristics, the NHS and NICE.

What the 10 mg dose is

Mounjaro 10 mg delivers 10 mg of tirzepatide per weekly dose from its own pre-filled KwikPen 4. Crucially, it is one of the three recommended maintenance doses, alongside 5 mg and 15 mg 1. That makes it a genuine target dose rather than a step in between, unlike the intermediate 7.5 mg.

It sits in the middle of the maintenance range: higher than the lowest maintenance dose of 5 mg, below the maximum of 15 mg 1. For many people 10 mg, reached and tolerated, is a settling point, though whether you stay there or go to 15 mg depends on your response and tolerance 1.

Our Mounjaro dose guide sets out the full schedule, and this page focuses on what is distinctive about 10 mg as a maintenance milestone.

The way the medicine works does not change at 10 mg: tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces hunger, increases fullness and slows stomach emptying 7. What a higher maintenance dose offers is a stronger version of that effect for people who need more than a lower dose provides, balanced against a somewhat higher chance of side effects 72.

How you reach 10 mg

You reach 10 mg by climbing the schedule: 2.5 mg for four weeks, then 5 mg, then 7.5 mg, then 10 mg, with each increase of 2.5 mg made after a minimum of four weeks at the current dose, if needed and tolerated 1. So 10 mg is typically reached no earlier than around three to four months into treatment, depending on how the steps go.

There is no requirement to reach 10 mg. The aim is the lowest dose that works for you, and some people do well on 5 mg 1. The climb to 10 mg happens only if a lower dose is not delivering enough and the higher dose is tolerated. Our article on why side effects sometimes return when you increase the dose covers the step-up experience.

You inject 10 mg once a week, on the same day where you can, rotating the site, with the same missed-dose rules as the other strengths 1.

Side effects at 10 mg

The side effects at 10 mg are the same gastrointestinal ones, and the trials do report 10 mg-specific figures. In the pooled weight management studies, at 10 mg nausea was reported by about 29.0 percent of people and any gastrointestinal disorder by about 55.8 percent, compared with 8.5 and 29.7 percent on placebo 2. Most were mild or moderate and decreased over time 2.

Discontinuation because of a gut side effect was higher at 10 mg, about 3.3 percent, than at 5 mg (1.9 percent), which fits the pattern that side effects and stopping for them tend to rise with dose 2. For hypoglycaemia in people with type 2 diabetes, the rate at 10 mg was similar to 15 mg and to placebo, with the risk increased mainly when combined with a sulphonylurea 2.

Other effects, not specific to 10 mg, include decreased appetite, dizziness, injection site reactions, a small heart-rate rise and hair loss 2. Our full side effects guide covers what is normal and what is not.

The serious risks apply at 10 mg as at any strength. The SmPC reports acute pancreatitis as an uncommon reaction, including post-marketing reports of necrotising and fatal cases, and asks anyone with persistent, severe abdominal pain to seek immediate medical attention 3. Gallbladder problems and dehydration from the gut effects are also cautioned, and the gut effects can be more noticeable in the week after stepping up to 10 mg before they settle 32.

At 10 mg (weight management trials)Figure
Nausea~29.0% vs 8.5% placebo 2
Any gastrointestinal disorder~55.8% vs 29.7% placebo 2
Stopped due to a gut side effect~3.3% (vs ~1.9% at 5 mg) 2
Dose positionA recommended maintenance dose (5, 10, 15 mg) 1
Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.

10 mg compared with the other doses

Compared with 5 mg, 10 mg is a higher maintenance dose with a somewhat higher chance of gut side effects and discontinuation for them 2. Compared with 15 mg, it is a step below the maximum 1. The intermediate strengths, 7.5 mg and 12.5 mg, are titration steps rather than maintenance targets 1.

Whether 10 mg or another dose is right is not a question of which is strongest but of which delivers enough benefit at an acceptable tolerance for you. NICE's six-month checkpoint, at least 5 percent weight loss on the highest tolerated dose, is the frame for that judgement 5. There is no benefit to chasing a higher dose if a lower one is working.

The trial data give a sense of the trade-off. Moving from 5 mg to 10 mg raised the proportion of people reporting nausea from about 24.6 to 29.0 percent, and those stopping for a gut side effect from about 1.9 to 3.3 percent 2. Those are modest increases, not dramatic ones, but they are the reason the dose is matched to the individual rather than pushed to the maximum by default 1.

Staying on 10 mg

For many people, 10 mg is where treatment settles, so it is worth knowing what ongoing use looks like. Once you are established on it, the gut side effects that were strongest during the climb tend to have eased, since the SmPC notes they peak around dose increases and decrease over time 2. The weekly routine, same day, fresh site, pen kept in the fridge until use, becomes settled 16.

Ongoing review still matters at a maintenance dose. NICE uses a six-month checkpoint, at least 5 percent weight loss on the highest tolerated dose, to decide whether to continue, and treatment continues to be framed as an adjunct to diet and activity rather than a standalone fix 5. Appetite returns if the medicine stops, so the habits built while on 10 mg are what protect progress afterwards 2.

If side effects flare again unexpectedly while settled on 10 mg, or new symptoms appear, that is worth raising rather than assuming it is normal. Persistent, severe abdominal pain in particular needs immediate medical attention, as it can signal pancreatitis 3.

It is also worth not treating 10 mg as a finish line to push beyond automatically. If it is working for you and tolerated, staying there is a valid long-term outcome, since 10 mg is a recommended maintenance dose; moving to 15 mg is for when 10 mg is not enough and the higher dose is tolerated 1. The aim throughout is the lowest dose that delivers a good result for you 1.

What to discuss with your prescriber

At 10 mg, useful things to raise include how you are tolerating it, whether the last increase has settled, and whether to stay at 10 mg or consider 15 mg 1. If you take a sulphonylurea or insulin for diabetes, those doses may need adjusting to reduce the risk of low blood sugar 3.

The interactions that apply at any dose apply at 10 mg. Tirzepatide can reduce the absorption of the contraceptive pill, so a barrier or non-oral method is advised for four weeks at the start and after each dose increase 8. It can slow the absorption of other oral medicines, and it must not be used in pregnancy 8. Tell your prescriber and pharmacist everything you take so these can be managed 8.

As with every strength, obtain Mounjaro only from a registered pharmacy after a clinical assessment 6. Prices vary between strengths privately, but the dose decision should be clinical, not driven by the cost of a pen.

Frequently asked questions

Is Mounjaro 10 mg a maintenance dose?

Yes. The SmPC lists 5, 10 and 15 mg as the recommended maintenance doses, so 10 mg is a genuine target dose, unlike the intermediate 7.5 mg 1. Many people settle at 10 mg, though whether you stay there or move to 15 mg depends on your response and tolerance 1.

What are the side effects of Mounjaro 10 mg?

Mainly gastrointestinal. In the weight management trials, nausea at 10 mg was reported by around 29.0 percent of people and any gut disorder by about 55.8 percent, mostly mild to moderate 2. Discontinuation for a gut side effect was about 3.3 percent, higher than at 5 mg, fitting the pattern that effects rise with dose 2.

Is 10 mg better than 5 mg of Mounjaro?

Not better, just higher. Both are recommended maintenance doses; 10 mg may deliver more weight loss for some, but with a somewhat higher chance of gut side effects 12. The aim is the lowest dose that works for you, judged against NICE's six-month checkpoint of at least 5 percent weight loss, not the highest dose 5.

How long does it take to reach 10 mg?

Typically no earlier than around three to four months, because you climb from 2.5 mg through 5 mg and 7.5 mg, with at least four weeks at each step before increasing 1. There is no requirement to reach 10 mg; the climb happens only if a lower dose is not enough and the higher one is tolerated 1.

Should I go from 10 mg to 15 mg?

Only if 10 mg is not delivering enough and 15 mg is tolerated; 15 mg is the maximum dose, reached by a 2.5 mg step up after at least four weeks 1. Higher doses tend to bring a somewhat higher chance of gut side effects 2. The aim is the lowest dose that works for you, judged against NICE's six-month checkpoint, so staying at 10 mg is valid if it is working 5. Discuss it with your prescriber.

Are the serious risks higher at 10 mg than 5 mg?

Common gut side effects and stopping for them are modestly more common at 10 mg than 5 mg, for example nausea around 29.0 percent versus 24.6 percent in the trials 2. The serious cautions, acute pancreatitis, gallbladder problems and dehydration, apply at both, and persistent, severe abdominal pain needs immediate medical attention at any dose 3. The dose is matched to the individual rather than maximised by default 1.

Your next step

Mounjaro 10 mg is a recommended maintenance dose and often a settling point: higher than 5 mg, below the 15 mg maximum, reached by stepping up gradually. Its side effects are the usual gut ones, a little more common than at 5 mg, and the choice between doses is about tolerated benefit, not strength for its own sake.

If you are on or approaching 10 mg, talk to your prescriber about how you are tolerating it and whether to stay or go higher. Only obtain Mounjaro from a registered pharmacy, and report side effects through the Yellow Card scheme. Remember the contraceptive and oral-medicine interactions apply at 10 mg, and that persistent, severe abdominal pain needs immediate medical attention whatever your dose.

Disclaimer

This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.

If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.

If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.

References

  1. 4.2 Posology (Mounjaro 10 mg)
  2. 4.8 Undesirable effects (weight management, 10 mg)
  3. 4.4 Special warnings (pancreatitis, gallbladder, dehydration, hypoglycaemia)
  4. 2 Composition
  5. 1 Recommendations (6-month review)
  6. Tirzepatide, registered pharmacy
  7. 5.1 Pharmacodynamic properties (mechanism)
  8. 4.5 Interactions / 4.6 pregnancy

Author Information

All of our medication and condition content is written by UK qualified pharmacists and doctors.

Anna Wedderburn

Authored by

Anna Wedderburn

Clinical Director

Nazmul Kadir

Reviewed by

Nazmul Kadir

Director & Superintendent Pharmacist

GPhC Number: 2215377

Review Date16 June 2026
Next Review16 June 2027
Published on16 June 2026
Last Update16 June 2026

Start your free weight loss consultation

Complete our online questionnaire so our clinical team can check eligibility for the desired treatment.

  • Takes less than 5 minutes to complete
  • Reviewed by our UK-based medical team
  • Approved treatments dispatched same day (before 3pm)
Anna Wedderburn

Anna Wedderburn

Clinical Director

Need something else?

We stock over 1102 treatments for 90 conditions